| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H40N6O7 |
| Molecular Weight | 632.7067 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(N)=O
InChI
InChIKey=XDRHVZLDLNGKLM-FLVVDCEDSA-N
InChI=1S/C33H40N6O7/c1-19(36-32(45)26(34)16-22-8-12-24(40)13-9-22)31(44)39-28(18-21-6-4-3-5-7-21)33(46)37-20(2)30(43)38-27(29(35)42)17-23-10-14-25(41)15-11-23/h3-15,19-20,26-28,40-41H,16-18,34H2,1-2H3,(H2,35,42)(H,36,45)(H,37,46)(H,38,43)(H,39,44)/t19-,20-,26+,27+,28+/m1/s1
Casokefamide is a synthetic peptide derived from the beta-casomorphin sequence, designed to increase the resistance to gastric proteases. . Casokefamide binds to both mu and delta-opioid receptors, while beta-casomorphins and its fragments are typical mu-opioid receptor agonists. Furthermore, casokefamide can affect gastric acid and pancreatic exocrine secretions and also gastrointestinal motility.
Originator
Approval Year
PubMed
Patents
ACTIVE MOIETY
